Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41586-020-2787-6 http://scihub22266oqcxt.onion/10.1038/s41586-020-2787-6 32967005!8136862!32967005     free     free     free       Nature 2020 ; 586 (7830): 509-515 Nephropedia Template TP {{tp|p=32967005|t=2020. Animal models for COVID-19 |pdf=|usr=}}{{32967005}} gab.com Text Animal models for COVID-19 JO: Nature http://www.kidney.de/pget.php?&tw=1&pmid=32967005 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronavirus into humans late in 2019 (first detected in Hubei province, China). As of 18 September 2020, SARS-CoV-2 has spread to 215 countries, has infected more than 30 million people and has caused more than 950,000 deaths. As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence of COVID-19. In February 2020, the World Health Organization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerate the testing of vaccines and therapeutic agents. Here we summarize the findings to date and provides relevant information for preclinical testing of vaccine candidates and therapeutic agents for COVID-19. Twit Text FOAVip Animal models for COVID-19 ????Nature http://www.kidney.de/pget.php?&tw=1&pmid=32967005 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32967005 #FOAvip English Wikipedia <ref>{{Cite pmid|32967005}}</ref> Animal models for COVID-19 #MMPMID32967005 Munoz-Fontela C; Dowling WE; Funnell SGP; Gsell PS; Riveros-Balta AX; Albrecht RA; Andersen H; Baric RS; Carroll MW; Cavaleri M; Qin C; Crozier I; Dallmeier K; de Waal L; de Wit E; Delang L; Dohm E; Duprex WP; Falzarano D; Finch CL; Frieman MB; Graham BS; Gralinski LE; Guilfoyle K; Haagmans BL; Hamilton GA; Hartman AL; Herfst S; Kaptein SJF; Klimstra WB; Knezevic I; Krause PR; Kuhn JH; Le Grand R; Lewis MG; Liu WC; Maisonnasse P; McElroy AK; Munster V; Oreshkova N; Rasmussen AL; Rocha-Pereira J; Rockx B; Rodriguez E; Rogers TF; Salguero FJ; Schotsaert M; Stittelaar KJ; Thibaut HJ; Tseng CT; Vergara-Alert J; Beer M; Brasel T; Chan JFW; Garcia-Sastre A; Neyts J; Perlman S; Reed DS; Richt JA; Roy CJ; Segales J; Vasan SS; Henao-Restrepo AM; Barouch DH Nature 2020[Oct]; 586 (7830): 509-515 PMID32967005show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronavirus into humans late in 2019 (first detected in Hubei province, China). As of 18 September 2020, SARS-CoV-2 has spread to 215 countries, has infected more than 30 million people and has caused more than 950,000 deaths. As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence of COVID-19. In February 2020, the World Health Organization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerate the testing of vaccines and therapeutic agents. Here we summarize the findings to date and provides relevant information for preclinical testing of vaccine candidates and therapeutic agents for COVID-19. |*Disease Models, Animal[MESH] |Animals[MESH] |Betacoronavirus/drug effects/immunology[MESH] |COVID-19[MESH] |COVID-19 Vaccines[MESH] |Coronavirus Infections/*drug therapy/immunology/*prevention & control[MESH] |Ferrets/virology[MESH] |Humans[MESH] |Mesocricetus/virology[MESH] |Mice[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/*drug therapy/immunology/*prevention & control[MESH] |Primates/virology[MESH] |SARS-CoV-2[MESH]Animal models for COVID-19 (epmc).pdf DeepDyve Pubget Overpricing